These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

641 related items for PubMed ID: 7578169

  • 21. Viremia after lung transplant: a cohort study on risk factors and symptoms associated with detection of Epstein-Barr virus.
    Mattner F, Hesse N, Fegbeutel C, Strüber M, Gottlieb J, Sohr D, Welte T, Schulz TF, Simon AR, Engelmann I.
    Prog Transplant; 2012 Jun; 22(2):155-60. PubMed ID: 22878072
    [Abstract] [Full Text] [Related]

  • 22. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
    Schubert S, Renner C, Hammer M, Abdul-Khaliq H, Lehmkuhl HB, Berger F, Hetzer R, Reinke P.
    J Heart Lung Transplant; 2008 Jan; 27(1):100-5. PubMed ID: 18187094
    [Abstract] [Full Text] [Related]

  • 23. Evaluation of Epstein-Barr virus antibodies, anti-VCA avidity by immunofluorescence and immunoblot assays for assessment of Epstein-Barr virus immunologic state.
    Sener AG, Afsar I, Pinar E.
    J Virol Methods; 2009 Aug; 159(2):300-2. PubMed ID: 19406156
    [Abstract] [Full Text] [Related]

  • 24. Antibody to the rheumatoid arthritis nuclear antigen. Its relationship to in vivo Epstein-Barr virus infection.
    Catalano MA, Carson DA, Niederman JC, Feorino P, Vaughan JH.
    J Clin Invest; 1980 May; 65(5):1238-42. PubMed ID: 6245108
    [Abstract] [Full Text] [Related]

  • 25. Epstein-Barr virus load in whole blood is associated with immunosuppression, but not with post-transplant lymphoproliferative disease in stable adult heart transplant patients.
    Doesch AO, Konstandin M, Celik S, Kristen A, Frankenstein L, Sack FU, Schnabel P, Schnitzler P, Katus HA, Dengler TJ.
    Transpl Int; 2008 Oct; 21(10):963-71. PubMed ID: 18564989
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The impact of monitoring Epstein-Barr virus PCR in paediatric bone marrow transplant patients: can it successfully predict outcome and guide intervention?
    Greenfield HM, Gharib MI, Turner AJ, Guiver M, Carr T, Will AM, Wynn RF.
    Pediatr Blood Cancer; 2006 Aug; 47(2):200-5. PubMed ID: 16206207
    [Abstract] [Full Text] [Related]

  • 28. [A comparison of the detection of IgM antibodies against the viral capsid antigen (VCA) of EBV (Epstein-Barr virus) in various groups of patients, using indirect immunofluorescence, indirect ELISA and reverse ELISA. Study of the diagnostic efficacy of the anti-VCA EBV IgM ELISA-VIDITEST kit].
    Pumannová M, Rezbová M, Svecová M, Hrbácková H, Novotná M, Ochotná J, Roubalová K.
    Klin Mikrobiol Infekc Lek; 2004 Aug; 10(4):186-90. PubMed ID: 15328576
    [Abstract] [Full Text] [Related]

  • 29. High incidence of elevated antibody titers to Epstein-Barr virus in patients with uveitis.
    Touge C, Agawa H, Sairenji T, Inoue Y.
    Arch Virol; 2006 May; 151(5):895-903. PubMed ID: 16362642
    [Abstract] [Full Text] [Related]

  • 30. [Variability in Epstein-Barr virus serological markers in adult kidney transplant recipients].
    Lauzurica R, Frías C, Bayés B, Ausina V, Romero R.
    Nefrologia; 2005 May; 25(2):185-90. PubMed ID: 15912656
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Dynamic EBV gene loads in renal, hepatic, and cardiothoracic transplant recipients as determined by real-time PCR light cycler.
    Leung E, Shenton BK, Green K, Jackson G, Gould FK, Yap C, Talbot D.
    Transpl Infect Dis; 2004 Dec; 6(4):156-64. PubMed ID: 15762933
    [Abstract] [Full Text] [Related]

  • 33. Adenotonsillar hypertrophy and Epstein-Barr virus in pediatric organ transplant recipients.
    Shapiro NL, Strocker AM.
    Laryngoscope; 2001 Jun; 111(6):997-1001. PubMed ID: 11404611
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Antibody formation against specific Epstein-Barr virus antigens in infectious mononucleosis with tonsillectomy in the acute phase of the disease].
    Sauerbrei A, Sprössig M, Wutzler P, Färber I, Schweizer H, Swoboda R, Wilke J.
    Laryngol Rhinol Otol (Stuttg); 1983 Apr; 62(4):170-4. PubMed ID: 6191167
    [Abstract] [Full Text] [Related]

  • 37. Infection after pediatric heart transplantation: results of a multiinstitutional study. The Pediatric Heart Transplant Study Group.
    Schowengerdt KO, Naftel DC, Seib PM, Pearce FB, Addonizio LJ, Kirklin JK, Morrow WR.
    J Heart Lung Transplant; 1997 Dec; 16(12):1207-16. PubMed ID: 9436132
    [Abstract] [Full Text] [Related]

  • 38. Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection.
    Aalto SM, Linnavuori K, Peltola H, Vuori E, Weissbrich B, Schubert J, Hedman L, Hedman K.
    J Med Virol; 1998 Nov; 56(3):186-91. PubMed ID: 9783683
    [Abstract] [Full Text] [Related]

  • 39. Infectious mononucleosis, Epstein-Barr virus, and chronic fatigue syndrome: a prospective case series.
    Fark AR.
    J Fam Pract; 1991 Feb; 32(2):202, 205-6, 209. PubMed ID: 1846641
    [Abstract] [Full Text] [Related]

  • 40. Serum Epstein-Barr virus DNA load in primary Epstein-Barr virus infection.
    Bauer CC, Aberle SW, Popow-Kraupp T, Kapitan M, Hofmann H, Puchhammer-Stöckl E.
    J Med Virol; 2005 Jan; 75(1):54-8. PubMed ID: 15543583
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 33.